Summary
The effects of alprazolam 0.5 mg and lorazepam 2 mg on cognitive and psychomotor skills were assessed in twelve normal volunteer subjects in a randomised, double-blind, crossover design. Single and multiple dose effects were monitored using a battery of tests comprising critical flicker fusion threshold (CFFT), choice reaction time (CRT), simulated car tracking, and subjective ratings of perceived sedation (LARS) and of sleep behaviour (LSEQ). Compared with placebo baseline scores, treatment with lorazepam 2 mg (both single and multiple doses) resulted in a widespread impairment of CRT, tracking accuracy, and CFFT. Single doses of alprazolam 0.5 mg reduced CFFT with respect to the placebo baseline. Single and multiple dose treatment with both drugs resulted in subjective reports of sedation, a reduction of sleep onset latency, and improved sleep quality. Only lorazepam 2 mg significantly disrupted the integrity of behaviour on waking from sleep. These results suggest important pharmacodynamic differences between the two drugs in the doses used.
Similar content being viewed by others
References
Aden GC, Thein SG (1980) Alprazolam compared to diazepam and placebo in the treatment of anxiety. J Clin Psychol 41: 245–248
Appel P, Bergen I, Harrer G (1971) Experience with WY-4036, a new tranquilliser from the benzodiazepine series. Arzneimittelforsch 21: 1083–1086
Botte L, Bienfait J, Dethier J, Evan P, Evrard JL, Fraipont J, Goffin L, Willemse P (1981) Clinical comparison between alprazolam and lorazepam: A multi-centre double-blind study. Acta Psychiatr Belg 81: 595–608
Cohn JB (1981) Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients. J Clin Psychiatry 42: 347–351
Collard J (1971) Initial psychopharmacological study of lorazepam (WY-4036). Arzneimittelforsch 21: 1091
Fabre LF, McLendon DM (1980) A double-blind study comparing the efficacy and safety of alprazolam with imipramine and placebo in primary depression. Curr Ther Res 27: 382–474
Feighner JP (1982) Benzodiazepines as antidepressants. Mod Probl Pharmacopsychiatry 18: 196–212
Hindmarch I (1975) A 1,4 benzodiazepine, temazepam: Its effect on some psychological aspects of sleep and behaviour. Arzneimittelforsch (Drug Res) 25: 1836–1839
Hindmarch I (1980) Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 10: 1189–209
Hindmarch I (1982) Critical flicker fusion frequency (CFFF): The effects of psychotropic compounds. Pharmacopsychiatria 15 (Suppl 1): 44–48
Hindmarch I (1983) Measuring the side-effects of psychoactive drugs: a pharmacodynamic profile of alprazolam. Alcohol Alcoholism 18: 361–367
Hindmarch I, Gudgeon AC (1980) The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol 10: 145–150
Hindmarch I, Parrott AC (1978) The effect of a sub-chronic administration of three dose levels of a 1,5 benzodiazepine derivative, clobazam, on subjective aspects of sleep and assessments of psychomotor performance the morning following night time medication. Arzneimittelforsch (Drug Res)28: 2169–2172
Hindmarch I, Subhan Z, Stoker MJ (1983) The effects of zimeldine and amitriptyline on car driving and psychomotor performance. Acta Psychiatr Scand 68: 141–146
Itil TM, Saletu B, Marasa J, Mucciardi AN (1972) Digital computer analysed awake and sleep EEG (sleep prints) in predicting the effects of triazolobenzodiazepine (U-31, 889). Pharmakopsychiatrie Neuropsychopharmakol 5: 225–240
Itoh H, Ohtsuka N, Kamishima K, Kaizawa S, Miura S (1977) A comparative study for the evaluation of antianxiety agents (lorazepam, diazepam and placebo), in neurosis. Folia Psychiatr Neurol J 31: 25–35
Kirk RE (1968) Experimental design. Procedures for the behavioural sciences. Wadsworth, Belmont
Parrott AC, Hindmarch I (1978) Clobazam, a 1,5 benzodiazepine derivative: Effects upon human psychomotor performance under different levels of task reinforcement. Arch Int Pharmacol Ther 232: 262–268
Parrott AC, Hindmarch I (1980) The leeds sleep evaluation questionnaire in psychopharmacological investigations — a review. Psychopharmacology 71: 173–179
Subhan Z, Hindmarch I (1983) The effects of acute doses of metaclazepam (KC 2547) on central nervous system activity, psychomotor performance and memory. Drugs Exp Clin Res 9: 567–572
Torres-Ruiz AT (1983) A double-blind study of alprazolam and lorazepam in the treatment of anxiety. J Clin Psychiatry 44: 60–62
Woodworth RS, Schlosberg H (1958) Experimental psychology. Methuen, London
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Subhan, Z., Harrison, C. & Hindmarch, I. Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep. Eur J Clin Pharmacol 29, 709–712 (1986). https://doi.org/10.1007/BF00615963
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00615963